EUS has recently evolved from a purely diagnostic procedure to an interventional technique aimed at delivering therapeutic agents at the site of puncture. The potential advantage of a tissue ablation device employed under EUS control is the real-time imaging guidance into the pancreas, which is difficult to reach by a percutaneous approach. We tested the safety and feasibility of EUS-guided Nd:YAG laser ablation in patients with stage IIb-III pancreatic duct adenocarcinoma (PDAC) after failed radio-chemiotherapy.
EUS-Guided Nd:YAG Laser Ablation of Locally Advanced Pancreatic Adenocarcinoma: Feasibility and Safety Study
Schena E;Faiella E;Silvestri S;
2016-01-01
Abstract
EUS has recently evolved from a purely diagnostic procedure to an interventional technique aimed at delivering therapeutic agents at the site of puncture. The potential advantage of a tissue ablation device employed under EUS control is the real-time imaging guidance into the pancreas, which is difficult to reach by a percutaneous approach. We tested the safety and feasibility of EUS-guided Nd:YAG laser ablation in patients with stage IIb-III pancreatic duct adenocarcinoma (PDAC) after failed radio-chemiotherapy.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
